Browse result page of CancerPDF Database

Please click on CancerPDF_ID for detailed information about peptide.

CancerPDF_IDPeptide seqProtein NameFluidMass/ZProfiling TechniqueCancer Type Expression RegulationPUBMED ID
CancerPDF_ID964 NANASerum7772.38MALDI-TOFColorectal cancer Upregulated and considered as candidate biomarker 23091368
CancerPDF_ID1168 NANASerum7763.77MALDI-TOFLung cancer Downregulated in cancer vs normal with average expression of peptide in cancer 2.86 and in normal 9.82 21082738
CancerPDF_ID1170 NANASerum7952.52MALDI-TOFLung cancer Downregulated in cancer vs normal with average expression of peptide in cancer 0.42 and in normal 0.68 21082738
CancerPDF_ID1174 NANASerum7563.89MALDI-TOFLung cancer Downregulated in cancer vs normal with average expression of peptide in cancer 0.35 and in normal 0.49 21082738
CancerPDF_ID1183 NANASerum7651.7MALDI-TOFLung cancer Downregulated in cancer vs normal with average expression of peptide in cancer 0.4 and in normal 0.67 21082738
CancerPDF_ID1192 NANASerum7007.68MALDI-TOFLung cancer Downregulated in cancer vs normal with average expression of peptide in cancer 0.59 and in normal 0.72 21082738
CancerPDF_ID3271 NANASerum7772.1MALDI-TOFOvarian cancer Differentially expressed between normal and patients 22086897
CancerPDF_ID3325 NANASerum7476.7MALDI-TOFOvarian cancer Differentially expressed between normal and patients 22086897
CancerPDF_ID3338 NANASerum7763.24MALDI-TOFNon-small cell lung cancer (NSCLC) Downregulated in cancer vs normal 22628229
CancerPDF_ID3341 NANASerum7563.83MALDI-TOFNon-small cell lung cancer (NSCLC) Downregulated in cancer vs normal 22628229
CancerPDF_ID3343 NANASerum7920.5MALDI-TOFNon-small cell lung cancer (NSCLC) Downregulated in cancer vs normal 22628229
CancerPDF_ID3351 NANASerum7468.37MALDI-TOFNon-small cell lung cancer (NSCLC) Upregulated in cancer vs normal 22628229
CancerPDF_ID3372 NANASerum7007.25MALDI-TOFNon-small cell lung cancer (NSCLC) Downregulated in cancer vs normal 22628229
CancerPDF_ID3374 NANASerum7651.87MALDI-TOFNon-small cell lung cancer (NSCLC) Downregulated in cancer vs normal 22628229
CancerPDF_ID8416 NANASerum7740.77MALDI-TOF"Breast cancer, Lung cancer, Rectal cancer" Frequency of peptide In lung cancer : 85.71% ; In Rectal cancer : 97.22% ; Breast cancer: 98%; In normal healthy individuals : 95.2% 23667664
CancerPDF_ID8493 NANASerum7458.63MALDI-TOF"Breast cancer, Lung cancer, Rectal cancer" "Frequency of peptide in rectal cancer : 41.67% , In normal healthy individuals : 5.2%" 23667664
CancerPDF_ID8657 NANASerum7637.05MALDI-TOF"Hepatocellular carcinoma, Liver cirrhosis, Chronic hepatitis" significantly different from that of normal 23915185
CancerPDF_ID12768 NANASerum7773MALDI-TOFCervical cancer Upregulated in Cervical squamous cell carcinoma vs healthy 26282206
CancerPDF_ID12769 NANASerum7643.01MALDI-TOFHepatocellular carcinoma Downregulated in cancer vs Healthy 25910294
CancerPDF_ID12770 NANASerum7927.69MALDI-TOFHepatocellular carcinoma Downregulated in cancer vs Healthy 25910294
CancerPDF_ID12771 NANASerum7833.44MALDI-TOFHepatocellular carcinoma Downregulated in cancer vs Healthy 25910294
CancerPDF_ID12773 NANASerum7771.17MALDI-TOFHepatocellular carcinoma Downregulated in cancer vs Healthy 25910294
CancerPDF_ID12775 NANASerum7896.09MALDI-TOFHepatocellular carcinoma Downregulated in cancer vs Healthy 25910294
CancerPDF_ID12805 NANASerum7788.6MALDI-TOFColorectal adenoma and Colorectal carcinoma "Differential Peptide Peaks in Colorectal Cancer, Colorectal Adenoma and Health Volunteer Group" 24289627
CancerPDF_ID12823 NANASerum7769.65MALDI-TOFColorectal adenoma and Colorectal carcinoma "Differential Peptide Peaks in Colorectal Cancer, Colorectal Adenoma and Health Volunteer Group" 24289627
CancerPDF_ID14325 NANASerum7822.5Magnetic bead based weak cation exchange chromatography(MB-WCX)Gastric cancer NA 21739109
CancerPDF_ID14355 NANASerum7772.04IMAC-MBBreast cancer NA 22521044
CancerPDF_ID14356 NANASerum7777.16IMAC-MBBreast cancer NA 22521044
CancerPDF_ID14358 NANASerum7637.05MB-WCXHepatocellular carcinoma NA 23915185